子社群 于重元 [19/19] 劉柯俊 [85/98] 劉滄梧 [119/125] 劉界元(2003-2010) [3/3] 夏和雄(1996-2012) [26/31] 夏興國 [51/54] 姜乃榕 [82/94] 常慧如 [39/44] 張俊彥 [234/254] 張光裕 [69/79] 張憶壽 [103/106] 張文祥 [52/53] 張書銘 [89/91] 彭汪嘉康(1996-2007) [120/126] 施能耀 [37/43] 李家惠 [29/29] 李岳倫 [48/49] 林素芳 [32/32] 楊奕馨 [41/42] 江士昇 [88/90] 沈哲宏 [14/16] 洪文俊 [88/88] 莊雙恩 [82/91] 蔡坤志 [32/34] 蔡慧珍 [66/71] 蘇勇曄 [40/40] 蘇振良 [24/25] 郭靜娟 [71/76] 陳尚鴻 [45/48] 陳振陽 [72/72] 陳立宗 [443/510] 陳美霞(2002-2009) [1/1] 陳詩政 [2/2] 陳雅雯 [38/39] 黃智興 [55/55] 黃道揚 [26/26] 丁兆治(2000-2004) [5/5] 其他 [464/471] 劉敏(1996-2007) [60/62] 劉玫英(2004-2006) [2/2] 吳成文(1996-2008) [53/55] 曾思文(1997-2007) [4/4] 李冠德(1997-2004) [4/6] 林景太(1999-2007) [5/5] 楊文光(1996-1999) [21/21] 王全正(1996-2003) [4/4] 莊聲宏(1997-2004) [11/11] 詹宗晃(2000-2008) [2/2] 賴基銘(2004-2008) [41/47] 阮麗蓉(2000-2006) [6/7] 陳俊叡(2003-2007) [6/6] 馬彥英(1997-1999) [1/1] 黃奇英(2005-2007) [9/10] 邻近社群 分子與基因醫學研究所 [921/964] 生技與藥物研究所 [830/1008] 生醫工程與奈米醫學研究所 [1214/1334] 免疫醫學研究中心 [224/236] 神經及精神醫學研究中心 [782/804] 細胞及系統醫學研究所 [755/815] 感染症與疫苗研究所 [1541/1618] 群體健康科學研究所 [2870/3000] 國家環境醫學研究所 [1560/1591] 國家蚊媒傳染病防治研究中心 [102/104] 高齡醫學暨健康福祉研究中心 [216/224] 論壇 [2/2] 生醫資源中心 [7/7] 研究生培育合作學程 [188/191] 核心儀器設施中心 [9/9] 病理核心實驗室 [14/14] 實驗動物中心 [8/8] 行政管理部門 [18/18] 社群统计 近3年内发表的文件:335(13.91%) 含全文笔数:2250(93.40%) 文件下载次数统计 下载大于0次:2250(100.00%) 下载大于100次:2250(100.00%) 全文下载总次数:1608490(30.01%) 最后更新时间: 2024-11-28 15:40 上传排行 数据加载中..... 下载排行 数据加载中..... 最近上传 Pathological response following neo... Registry of genetic alterations of ... Activated single nucleotide mismatc... Taiwan nationwide study of first-li... The effectiveness of virtual passpo... Special Issue "Bioinformatics ... Evaluating a natural language proce... The clinicopathological significanc... Hypoxia in drug resistance and radi... DKK1 as a chemoresistant protein mo...

跳至: (选择年份) 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994 1993 1992 1991 1990 1985 1980 1975 1970 1960 1950 (选择月份) January February March April May June July August September October November December 或输入年份:

由新到旧排序 由最旧的开始

显示项目1-25 / 2409. (共97页) 1 2 3 4 5 6 7 8 9 10 > >> 每页显示[10|25|50]项目

日期	题名	關聯
2025-01-15	Activated single nucleotide mismatch determination through toehold-embedded hairpin-mediated strand displacement reaction alongside CRISPR-Cas12a for detection of TP53 point mutation	Sensors and Actuators B-Chemical. 2025 Jan 15;423:Article number 136751.
2024-12	Integrating predictive coding and a user-centric interface for enhanced auditing and quality in cancer registry data	Computational and Structural Biotechnology Journal. 2024 Dec;24:322-333.
2024-11	Cytoplasmic lipid droplets predict worse prognosis in diffuse large B-cell lymphoma: Next-generation sequencing deciphering lipogenic genes	American Journal of Surgical Pathology. 2024 Nov 1;48(11):1425-1438.
2024-11	Pathological response following neoadjuvant immune checkpoint inhibitors in patients with hepatocellular carcinoma: A cross-trial, patient-level analysis	Lancet. Oncology. 2024 Nov;25(11):1465-1475.
2024-10-11	Taiwan nationwide study of first-line ALK-TKI therapy in ALK-positive lung adenocarcinoma	Targeted Oncology. 2024 Oct 11;Article in Press.
2024-10-01	Special Issue "Bioinformatics study in human diseases: Integration of omics data for personalized medicine"	International Journal of Molecular Sciences. 2024 Oct 01;25(19):Article number 10579.
2024-10	A phase 1 study of biweekly nab-paclitaxel/oxaliplatin/S-1/LV for advanced upper gastrointestinal cancers: TCOG T1216 study	Oncologist. 2024 Oct 3;29(10):e1396-e1405.
2024-09-30	Registry of genetic alterations of Taiwan non-small cell lung cancer by comprehensive next-generation sequencing: A real-world cohort study-Taiwan cooperative oncology group T1521	JCO Global Oncology. 2024 Sep 30;10:Article number e2400125.
2024-09-27	DKK1 as a chemoresistant protein modulates oxaliplatin responses in colorectal cancer	Oncogenesis. 2024 Sep 27;13:Article number 34.
2024-09-26	The effectiveness of virtual passport, an app-based intervention, for dementia care	Frontiers in Psychiatry. 2024 Sep 26;15:Article number 1457923.
2024-09-20	The mitochondrial stress signaling tunes immunity from a view of systemic tumor microenvironment and ecosystem	iScience. 2024 Sep 20;27(9):Article number 110710.
2024-09-20	Evaluating a natural language processing–driven, AI-assisted international classification of diseases, 10th revision, clinical modification, coding system for diagnosis related groups in a real hospital environment: Algorithm development and validation st	Journal of Medical Internet Research. 2024 Sep 20;26:Article number e58278.
2024-09-18	Crosstalk between FTH1 and PYCR1 dysregulates proline metabolism and mediates cell growth in KRAS-mutant pancreatic cancer cells	Experimental and Molecular Medicine. 2024 Sep 18;56:2065-2081.
2024-09-10	Characteristics and transcriptional regulators of spontaneous epithelial-mesenchymal transition in genetically unperturbed patient-derived non-spindled breast carcinoma	Breast Cancer Research. 2024 Sep 10;26:Article number 130.
2024-09-05	BRCA genetic testing and counseling in breast cancer: How do we meet our patients' needs?	npj Breast Cancer. 2024 Sep 05;10:Article number 77.
2024-09-03	EMP2 induces cytostasis and apoptosis via the TGFBeta/SMAD/SP1 axis and recruitment of P2RX7 in urinary bladder urothelial carcinoma (vol 44, pg 1133, 2021)	Cellular Oncology. 2024 Sep 03;Article in Press.
2024-09-03	The clinicopathological significance and prognostic impact of 14-3-3σ/stratifin expression on patients with surgically resectable intrahepatic cholangiocarcinoma	Asian Journal of Surgery. 2024 Sep 03;Article in Press.
2024-08-28	Clinical outcomes and histologic findings of patients with hepatocellular carcinoma with durable partial response or durable stable disease after receiving atezolizumab plus bevacizumab	Journal of Clinical Oncology. 2024 Aug 28;Article in Press.
2024-08-20	Nivolumab plus chemotherapy in patients with HER2-negative, previously untreated, unresectable, advanced, or recurrent gastric/gastroesophageal junction cancer: 3-year follow-up of the ATTRACTION-4 randomized, double-blind, placebo-controlled, phase 3 tri	Gastric Cancer. 2024 Aug 20;Article in Press.
2024-08-16	The miRNAs 203a/210-3p/5001-5p regulate the androgen/androgen receptor/YAP-induced migration in prostate cancer cells	Cancer Medicine. 2024 Aug 16;13(16):Article number e70106.
2024-08-06	Pan-Asian adapted ESMO clinical practice guidelines for the diagnosis, treatment and follow-up of patients with biliary tract cancer	ESMO Open. 2024 Aug 06;9(8):Article number 103647.
2024-08	Dominant dystrophic epidermolysis bullosa is associated with glycolytically active GATA3+ T helper 2 cells which may contribute to pruritus in lesional skin	British Journal of Dermatology. 2024 Aug;191(2):252-260.
2024-08	Durvalumab or placebo plus gemcitabine and cisplatin in participants with advanced biliary tract cancer (TOPAZ-1): Updated overall survival from a randomised phase 3 study	Lancet. Gastroenterology and Hepatology. 2024 Aug;9(8):694-704.
2024-08	Photothermal temperature-modulated cancer metastasis harnessed using proteinase-triggered assembly of near-infrared II photoacoustic/photothermal nanotheranostics	ACS Applied Materials and Interfaces. 2024 Aug 7;16(31):40611-40627.
2024-07-27	Current advances of oral cancer in Taiwan	Oral Diseases. 2024 Jul 27;Article in Press.

显示项目1-25 / 2409. (共97页) 1 2 3 4 5 6 7 8 9 10 > >> 每页显示[10|25|50]项目